Can osteoporosis affect children or teenagers? 

While osteoporosis is typically viewed as a condition of later life, it can, in rare circumstances, affect children and teenagers. In the UK, bone thinning in the young is usually referred to as juvenile osteoporosis. Unlike adult osteoporosis, which is often a result of the natural ageing process, bone loss in children is almost always ‘secondary,’ meaning it is caused by an underlying medical condition or the medication used to treat it. Because childhood and adolescence are the most critical periods for building a strong skeleton, any interruption to bone development during these years can have significant long-term implications for skeletal health. 

What We’ll Discuss in This Article 

• The concept of ‘Peak Bone Mass’ and why it matters 

• Identifying the causes: Secondary versus Idiopathic Juvenile Osteoporosis 

• How medical conditions like Crohn’s or Cystic Fibrosis affect young bones 

• The impact of long-term steroid use in children 

• Symptoms to look for: From back pain to unusual fractures 

• The UK clinical pathway: How paediatricians diagnose and manage bone health 

The importance of the ‘Peak Bone Mass’ window. 

Childhood and the teenage years are the ‘golden era’ for bone building. During this time, the body is exceptionally efficient at depositing minerals into the skeletal matrix. Most people reach their Peak Bone Mass, the maximum density and strength their bones will ever have, by their late twenties. 

If a child develops osteoporosis, they are not just losing bone; they are failing to build the ‘bone bank’ they will need for the rest of their lives. According to the Royal Osteoporosis Society, a low peak bone mass in early adulthood is one of the strongest predictors of fractures in later life. 

Secondary causes are the most common in the young. 

In the vast majority of UK cases, osteoporosis in a child is a secondary effect of another health issue. This happens when a condition interferes with how the body absorbs nutrients or how bone cells function. 

• Inflammatory Conditions: Diseases like Juvenile Idiopathic Arthritis (JIA) or Crohn’s disease can cause systemic inflammation that directly triggers bone-dissolving cells. 

• Malabsorption: Conditions such as Celiac disease or Cystic Fibrosis can prevent the gut from absorbing the calcium and vitamin D essential for bone growth. 

• Medications: Long-term use of corticosteroids (like prednisolone) for asthma or inflammatory conditions is a well-known cause of bone thinning in children. 

• Mobility Issues: Children with conditions like Cerebral Palsy who have limited weight-bearing activity may not provide the ‘mechanical stress’ needed to signal bones to grow strong. 

What is Idiopathic Juvenile Osteoporosis (IJO)? 

In very rare cases, a child may develop osteoporosis without any identifiable underlying cause. This is known as Idiopathic Juvenile Osteoporosis. It usually occurs just before the onset of puberty. 

While the exact cause is unknown, most children with IJO will experience a significant improvement in their bone density once they complete puberty. During the active phase, however, they are at high risk of fractures, particularly in the spine and the ends of the long bones. In the UK, these children are managed by specialist paediatric metabolic bone units. 

Recognising the signs in a child or teenager. 

Diagnosing osteoporosis in the young can be difficult because children often don’t complain of symptoms until a fracture occurs. Signs that may warrant a medical review include: 

1. Unexplained Back Pain: This can be a sign of ‘silent’ vertebral compression fractures. 

2. A Change in Posture: Such as a developing curve in the spine or a loss of height. 

3. Multiple Fractures: Especially if they occur from minor impacts, like a trip on a carpet. 

4. Difficulty Walking: Or a new limp that doesn’t have a clear cause. 

The UK clinical pathway for young patients. 

If a paediatrician suspects bone thinning, the assessment in the UK follows a specific protocol: 

• DEXA Scan with Paediatric Software: Standard DEXA scans are designed for adults. Children must be scanned using specialised software that accounts for their smaller size and growing bones. 

• Blood and Urine Tests: To check for vitamin D deficiency, calcium levels, and markers of bone turnover. 

• Genetic Testing: To rule out other rare conditions like Osteogenesis Imperfecta (brittle bone disease). 

• Management: Treatment focuses on treating the underlying cause, ensuring a high-calcium diet, and carefully managed physical activity. In severe cases, specialist paediatricians may prescribe bisphosphonates, though this is managed under strict hospital supervision. 

Conclusion 

While rare, osteoporosis can affect children and teenagers, usually as a result of an underlying medical condition or long-term medication use. Because these years are vital for achieving peak bone mass, early identification and management are crucial to protect the child’s future skeletal health. In the UK, young people with bone health concerns are supported by specialist paediatric teams who focus on building bone density through nutrition, activity, and medical intervention. If you are concerned about your child’s bone strength or if they have suffered multiple fractures, seek a medical review. If they experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article examines the clinical presentation and management of juvenile bone loss within the UK healthcare system. It has been written and reviewed by Dr. Stefan Petrov, a UK-trained physician, to ensure the information is accurate and reflects current NHS and British Paediatric & Adolescent Bone Group standards. The content is designed to help parents and carers understand the unique challenges of bone health in the young.